|
1
|
Laslett LJ, Alagona P Jr, Clark BA III,
Drozda JP Jr, Saldivar F, Wilson SR, Poe C and Hart M: The
worldwide environment of cardiovascular disease: Prevalence,
diagnosis, therapy, and policy issues: A report from the American
College of Cardiology. J Am Coll Cardiol. 60 (25 Suppl):S1–S49.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dharmakidari S, Bhattacharya P and
Chaturvedi S: Carotid artery stenosis: Medical therapy, surgery,
and stenting. Curr Neurol Neurosci Rep. 17:772017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Libby P, Bornfeldt KE and Tall AR:
Atherosclerosis: Successes, surprises, and future challenges. Circ
Res. 118:531–534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Yang C, Zhang L and Yang P:
MicroRNA-210 induces endothelial cell apoptosis by directly
targeting PDK1 in the setting of atherosclerosis. Cell Mol Biol
Lett. 22:32017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen M, Ren L, Meng Y, Shi L, Chen L, Yu
B, Wu Q and Qi G: The protease inhibitor E64d improves
ox-LDL-induced endothelial dysfunction in human aortic endothelial
cells. Can J Physiol Pharmacol. 96:120–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen X, Yan CC, Zhang X and You ZH: Long
non-coding RNAs and complex diseases: From experimental results to
computational models. Brief Bioinform. 18:558–576. 2017.PubMed/NCBI
|
|
7
|
Liu Y, Zheng L, Wang Q and Hu YW: Emerging
roles and mechanisms of long noncoding RNAs in atherosclerosis. Int
J Cardiol. 228:570–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan JX: LncRNA H19 promotes
atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur
Rev Med Pharmacol Sci. 21:322–328. 2017.PubMed/NCBI
|
|
9
|
Shan K, Jiang Q, Wang XQ, Wang YN, Yang H,
Yao MD, Liu C, Li XM, Yao J, Liu B, et al: Role of long non-coding
RNA-RNCR3 in atherosclerosis-related vascular dysfunction. Cell
Death Dis. 7:e22482016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu X, Li Z, Zheng H, Chan MT and Wu WK:
NEAT1: A novel cancer-related long non-coding RNA. Cell Prolif.
50:2017. View Article : Google Scholar
|
|
11
|
Huang-Fu N, Cheng JS, Wang Y, Li ZW and
Wang SH: Neat1 regulates oxidized low-density lipoprotein-induced
inflammation and lipid uptake in macrophages via paraspeckle
formation. Mol Med Rep. 17:3092–3098. 2018.PubMed/NCBI
|
|
12
|
Wang L, Xia JW, Ke ZP and Zhang BH:
Blockade of NEAT1 represses inflammation response and lipid uptake
via modulating miR-342-3p in human macrophages THP-1 cells. J Cell
Physiol. 234:5319–5326. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aryal B, Singh AK, Rotllan N, Price N and
Fernández-Hernando C: MicroRNAs and lipid metabolism. Curr Opin
Lipidol. 28:273–280. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li M, Wang J and Liu H: Downregulation of
miR-638 promotes progression of breast cancer and is associated
with prognosis of breast cancer patients. Onco Targets Ther.
11:6871–6877. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Zhang D, Jiang J and Dong L: Loss
of miR-638 promotes invasion and epithelial-mesenchymal transition
by targeting SOX2 in hepatocellular carcinoma. Oncol Rep.
37:323–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Paraskevopoulou MD and Hatzigeorgiou AG:
Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol.
1402:271–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Ying G, Wang J, Jung Y, Lu J, Zhu
J, Pienta KJ and Taichman RS: Characterization of phosphoglycerate
kinase-1 expression of stromal cells derived from tumor
microenvironment in prostate cancer progression. Cancer Res.
70:471–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou T, Ding JW, Wang XA and Zheng XX:
Long noncoding RNAs and atherosclerosis. Atherosclerosis.
248:51–61. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng DH, Wang X, Lu LN, Chen DL, Chen JM,
Lin FM and Xu XB: MiR-638 serves as a tumor suppressor by targeting
HOXA9 in glioma. Eur Rev Med Pharmacol Sci. 22:7798–7806.
2018.PubMed/NCBI
|
|
22
|
Zhao P, Zhang BL, Liu K, Qin B and Li ZH:
Overexpression of miR-638 attenuated the effects of
hypoxia/reoxygenation treatment on cell viability, cell apoptosis
and autophagy by targeting ATG5 in the human cardiomyocytes. Eur
Rev Med Pharmacol Sci. 22:8462–8471. 2018.PubMed/NCBI
|
|
23
|
Nakajima K, Nakano T and Tanaka A: The
oxidative modification hypothesis of atherosclerosis: The
comparison of atherogenic effects on oxidized LDL and remnant
lipoproteins in plasma. Clin Chim Acta. 367:36–47. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong Y, Fernandes C, Liu Y, Wu Y, Wu H,
Brophy ML, Deng L, Song K, Wen A, Wong S, et al: Role of
endoplasmic reticulum stress signalling in diabetic endothelial
dysfunction and atherosclerosis. Diab Vasc Dis Res. 14:14–23. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gimbrone MA Jr and Garcia-cardena G:
Endothelial cell dysfunction and the pathobiology of
atherosclerosis. Circ Res. 118:620–636. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hainsworth AH, Oommen AT and Bridges LR:
Bridges, Endothelial cells and human cerebral small vessel disease.
Brain Pathol. 25:44–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goveia J, Stapor P and Carmeliet P:
Principles of targeting endothelial cell metabolism to treat
angiogenesis and endothelial cell dysfunction in disease. EMBO Mol
Med. 6:1105–1120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Osorio-Fuentealba C, Contreras-Ferrat AE,
Altamirano F, Espinosa A, Li Q, Niu W, Lavandero S, Klip A and
Jaimovich E: Electrical stimuli release ATP to increase GLUT4
translocation and glucose uptake via PI3Kγ-Akt-AS160 in skeletal
muscle cells. Diabetes. 62:1519–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishikawa M, Iwamoto T, Nakamura T, Doyle
A, Fukumoto S and Yamada Y: Pannexin 3 functions as an ER Ca(2+)
channel, hemichannel, and gap junction to promote osteoblast
differentiation. J Cell Biol. 193:1257–1274. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng A, Wang S, Yang D, Xiao R and
Mattson MP: Calmodulin mediates brain-derived neurotrophic factor
cell survival signaling upstream of Akt kinase in embryonic
neocortical neurons. J Biol Chem. 278:7591–7599. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lay AJ, Jiang XM, Kisker O, Flynn E,
Underwood A, Condron R and Hogg PJ: Phosphoglycerate kinase acts in
tumour angiogenesis as a disulphide reductase. Nature. 408:869–873.
2000. View Article : Google Scholar : PubMed/NCBI
|
